Pluvicto® now publicly funded in provinces covering most Canadians, offering renewed hope to those facing progressive PSMA-positive metastatic castration-resistant prostate cancer Momentum builds nationwide as more jurisdictions recognize radioligand as… Read More
SAN FRANCISCO, CA & VANCOUVER, BC — Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, announced the appointment of Brad Dahms… Read More
Capstan’s lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo, and is… Read More
Getinge announces the extension of its Servo-c ventilator with a neonatal option, transforming it into a universal solution that supports respiratory care for all patient categories – from fragile premature… Read More
From a young age, Dr. Huawei Li found himself curious about biodevices and how they worked. He recalls a defining moment in his childhood—watching his father use a lancing device… Read More
